In Vivo Evaluation Using Gamma Scintigraphy - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

In Vivo Evaluation Using Gamma Scintigraphy
The authors discuss gamma scintigraphy as a technique for in vivo evaluation of drugs and delivery systems.


Pharmaceutical Technology


References

1. S. Jain, P. Dani, and R.K. Sharma, Crit. Rev. Ther. Drug 26 (4), 373–426 (2009).

2. S.P. Newman, P.H. Hirst, and I.R. Wilding, Eur. J. Pharm. Sci. 18 (1), 19–22 (2003).

3. Y.S.R. Krishnaina, S. Satyanarayana, and Y.V. Rama Prasad, J. Pharm. Sci. 5 (1), 24–28 (2002).

4. C.G. Wilson and N. Washington, "Gamma Scinitigraphy in the Analysis of the Behavior of Controlled Release Systems," in Handbook of Pharmaceutical Controlled Release Technology (Marcel Dekker, New York, 1st ed., 2005), pp. 551–565.

5. N.K. Jain, "Colon-Specific Drug Delivery Systems," in Advances in Controlled and Novel Drug Delivery (CBS Publishers, New Delhi, India, 1st ed., 2006), pp. 104–109.

6. I.R. Wilding, A.J. Coupe, and S.S. Davis, Adv. Drug. Deliver. Rev. 46 (1), 103–124 (2001).

7. "H.F. Solomn, H.D. Burns, and R.E. Gibson, Drug. Dev. Ind. Pharm. 16 (18), 2655–2673 (1990).

8. G. Meseguer, R. Gurny, and P. Buri, J. Drug Target. 2 (4), 269–288 (1994).

9. A.W. Basit et al., Eur. J. Pharm. Sci. 21 (2–23), 179–189 (2004).

10. "Methods of Radiolabeling," Quotient Bioresearch (Cambridgeshire, UK), http://www.quotientbioresearch.com/methods-radiolabeling/, accessed Oct. 18, 2010.

12. G.A. Digenis, E.P. Sandefer, R.C. Page, and W.J. Doll, Pharm. Sci. Technol. Today, 1 (3), 100–107 (1998).

13. L. Yang, J.S. Chu, and J.A. Fix, "Int. J. Pharm. 235 (1–2), 1–15 (2002).

14. S. Connolly, CRS Newlsetter 25 (4), 16–17 (2008).

15. M.S. Berridges, D.L. Heald, and Z. Lee, Drug. Dev. Res. 59 (2), 208–209 (2003).

16. K. Jones, "New Technology Combo Drives Once-Daily Drug Formulation," http://www.iptonline.com/articles/public/IPT_26_p66nonprint.pdf, accessed Sept. 27, 2010.

17. A.K. Singh, N. Bhardwaj, and A. Bhatnagar, Indian J. Pharm. Sci. 66 (1), 18–25 (2004).

18. "Pharmacoscintigraphy," Quotient Bioresearch (Cambridgeshire, UK), http://www.quotientbioresearch.com/pharmacoscintigraphy, accessed Oct. 18, 2010.

19. P.P. Hazari, et al., Bioconjugate. Chem. 21 (2), 229–239 (2010).

20. A. Pathak et al., ACS. Nano. 3 (6), 1493–1505 (2009).

21. D. Wang et al., Mol. Pharm. 3 (6), 717–725 (2006).

22. IAEA, "Radiation Protection Procedures," in International Atomic Energy Agency Safety Series (New York, 1978).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
26%
Oversee medical treatment of patients in the US.
12%
Provide treatment for patients globally.
10%
All of the above.
43%
No government involvement in patient treatment or drug development.
10%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Source: Pharmaceutical Technology,
Click here